Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 4:39 pm Sale | 2020-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | RA Capital Management, L.P. | 4,179,067 9.500% | -1,243,245![]() (-22.93%) | Filing History |
| 2021-02-16 4:39 pm Sale | 2020-12-31 | 13G | Verastem, Inc. VSTM | RA Capital Management, L.P. | 0 0.000% | -760,771![]() (Position Closed) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Travere Therapeutics, Inc. TVTX | RA Capital Management, L.P. | 4,557,867 8.900% | 4,557,867![]() (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | RA Capital Management, L.P. | 5,368,451 6.500% | 5,368,451![]() (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Curis, Inc. CRIS | RA Capital Management, L.P. | 385,390 8.500% | 385,390![]() (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE | RA Capital Management, L.P. | 1,823,520 5.900% | 1,823,520![]() (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR | RA Capital Management, L.P. | 58,267 9.900% | 3,318![]() (+6.04%) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Ascendis Pharma A/S ASND | RA Capital Management, L.P. | 5,865,338 10.900% | 46,476![]() (+0.80%) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | BCTG Acquisition Corp. BCTG | RA Capital Management, L.P. | 1,250,000 5.800% | 1,250,000![]() (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Dyne Therapeutics, Inc. DYN | RA Capital Management, L.P. | 2,805,045 6.200% | 2,805,045![]() (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | RA Capital Management, L.P. | 950,238 9.700% | 950,238![]() (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Frazier Lifesciences Acquisition Corporation FLAC | RA Capital Management, L.P. | 1,000,000 7.000% | 1,000,000![]() (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Geron Corporation GERN | RA Capital Management, L.P. | 31,114,941 9.990% | 31,114,941![]() (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Helix Acquisition Corp. HLXA | RA Capital Management, L.P. | 700,000 5.900% | 700,000![]() (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | ImmunoGen, Inc. IMGN | RA Capital Management, L.P. | 18,417,458 9.800% | 18,417,458![]() (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | FIVE PRIME THERAPEUTICS INC FPRX | RA Capital Management, L.P. | 4,285,161 9.800% | 4,285,161![]() (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Inhibrx Biosciences, Inc. INBX | RA Capital Management, L.P. | 2,129,003 5.600% | 2,129,003![]() (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Kinnate Biopharma Inc. KNTE | RA Capital Management, L.P. | 3,593,052 8.300% | 3,593,052![]() (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Inozyme Pharma, Inc. INZY | RA Capital Management, L.P. | 2,003,653 8.600% | 2,003,653![]() (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Larimar Therapeutics, Inc. LRMR | RA Capital Management, L.P. | 1,515,151 9.900% | 1,515,151![]() (New Position) | Filing History |

